Literature DB >> 17042747

Candida biofilms on implanted biomaterials: a clinically significant problem.

Gordon Ramage1, José Pedro Martínez, José Luis López-Ribot.   

Abstract

In recent years there has been an increasing appreciation that microbial biofilms are ubiquitous, which has resulted in a number of studies on infectious diseases from a biofilm perspective. Biofilms are defined as structured microbial communities that are attached to a surface and encased in a matrix of exopolymeric material. A wide range of biomaterials used in clinical practice have been shown to support colonization and biofilm formation by Candida spp., and the increase in Candida infections in the last decades has almost paralleled the increase and widespread use of a broad range of medical implant devices, mainly in populations with impaired host defenses. Formation of Candida biofilms has important clinical repercussions because of their increased resistance to antifungal therapy and the ability of cells within biofilms to withstand host immune defenses. Further recognition and understanding of the role of Candida biofilms in human infection should help in the clinical management of these recalcitrant infections.

Entities:  

Mesh:

Year:  2006        PMID: 17042747     DOI: 10.1111/j.1567-1364.2006.00117.x

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  164 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

2.  The Activities of Adhesion and Biofilm Formation by Candida tropicalis Clinical Isolates Display Significant Correlation with Its Multilocus Sequence Typing.

Authors:  Shuan Bao Yu; Wen Ge Li; Xiao Shu Liu; Jie Che; Jin Xing Lu; Yuan Wu
Journal:  Mycopathologia       Date:  2017-01-13       Impact factor: 2.574

3.  Electrochemical Detection of Small Molecule Induced Pseudomonas aeruginosa Biofilm Dispersion.

Authors:  Alex J Robb; Sergey Vinogradov; Allison S Danell; Eric Anderson; Meghan S Blackledge; Christian Melander; Eli G Hvastkovs
Journal:  Electrochim Acta       Date:  2018-03-02       Impact factor: 6.901

4.  Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation.

Authors:  Emma J Robertson; Arturo Casadevall
Journal:  Appl Environ Microbiol       Date:  2009-02-27       Impact factor: 4.792

5.  [MUW researcher of the month].

Authors:  Kristina Bertl
Journal:  Wien Klin Wochenschr       Date:  2013-12       Impact factor: 1.704

6.  Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.

Authors:  Jianlan You; Lin Du; Jarrod B King; Brian E Hall; Robert H Cichewicz
Journal:  ACS Chem Biol       Date:  2013-02-14       Impact factor: 5.100

7.  In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms.

Authors:  Semanti Sarkar; Priya Uppuluri; Christopher G Pierce; Jose L Lopez-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

Review 8.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.

Authors:  Gordon Ramage; Anto Jose; Leighann Sherry; David F Lappin; Brian Jones; Craig Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

10.  Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.

Authors:  A V Ferreira; C G Prado; R R Carvalho; K S T Dias; A L T Dias
Journal:  Mycopathologia       Date:  2013-03-27       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.